{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cancer", "MicroRNA-425", "Signaling pathways"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37332071", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "01"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.1007/s12033-023-00756-5"], "Journal": {"ISSN": "1559-0305", "JournalIssue": {"Volume": "66", "Issue": "7", "PubDate": {"Year": "2024", "Month": "Jul"}}, "Title": "Molecular biotechnology", "ISOAbbreviation": "Mol Biotechnol"}, "ArticleTitle": "MicroRNA-425: A Pivotal Regulator Participating in Tumorigenesis of Human Cancers.", "Pagination": {"StartPage": "1537", "EndPage": "1551", "MedlinePgn": "1537-1551"}, "Abstract": {"AbstractText": ["MicroRNAs (miRNAs) are small single-stranded regulatory RNAs that are shown to be dysregulated in a wide array of human cancers. MiRNAs play critical roles in cancer progression and function as either oncogenes or tumor suppressors through modulating various target genes. Therefore, they possess great potential as diagnostic and therapeutic targets for cancer detection and treatment. In particular, recent studies have illustrated that miR-425 is also dysregulated in various human malignancies and plays a fundamental role in cancer initiation and progression. miR-425 has been reported to function as a dual-role miRNA participating in the regulation of cellular processes, including metastasis, invasion, and cell proliferation by modulating multiple signaling pathways, such as TGF-\u03b2, Wnt, and P13K/AKT pathways. Therefore, regarding recent researches showing the high therapeutic potential of miR-425, in this review, we have noted the impact of its dysregulation on signaling pathways and various aspects of tumorigenesis in a variety of human cancers."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Higher Education Institute of Rab-Rashid, Tabriz, Iran."}], "LastName": "Sameti", "ForeName": "Pouriya", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Amini", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Advanced Technologies, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Oroojalian", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Baghay Esfandyari", "ForeName": "Yalda", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Tohidast", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Rahmani", "ForeName": "Seyed Ali", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran."}], "LastName": "Azarbarzin", "ForeName": "Shirin", "Initials": "S"}, {"Identifier": ["0000-0002-4515-8675"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. mokhtarzadehah@tbzmed.ac.ir."}], "LastName": "Mokhtarzadeh", "ForeName": "Ahad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. baradaranb@tbzmed.ac.ir."}], "LastName": "Baradaran", "ForeName": "Behzad", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Mol Biotechnol", "NlmUniqueID": "9423533", "ISSNLinking": "1073-6085"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN425 microRNA, human"}], "MeshHeadingList": [{"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": ["genetics"], "DescriptorName": "Carcinogenesis"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Animals"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68, 394\u2013424.", "ArticleIdList": ["30207593"]}, {"Citation": "Hassanpour, S. H., & Dehghani, M. (2017). Review of cancer from perspective of molecular. Journal of Cancer Research and Practice, 4, 127\u2013129."}, {"Citation": "Jahanafrooz, Z., Baradaran, B., Mosafer, J., Hashemzaei, M., Rezaei, T., Mokhtarzadeh, A., & Hamblin, M. R. (2020). Comparison of DNA and mRNA vaccines against cancer. Drug Discovery Today, 25, 552\u2013560.", "ArticleIdList": ["31843577"]}, {"Citation": "Fouad, Y. A., & Aanei, C. (2017). Revisiting the hallmarks of cancer. American Journal of Cancer Research, 7, 1016.", "ArticleIdList": ["28560055", "5446472"]}, {"Citation": "Asl, E. R., Amini, M., Najafi, S., Mansoori, B., Mokhtarzadeh, A., Mohammadi, A., Lotfinejad, P., Bagheri, M., Shirjang, S., & Lotfi, Z. (2021). Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression. Life Science, 278, 119499."}, {"Citation": "Longley, D., & Johnston, P. (2005). Molecular mechanisms of drug resistance. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 205, 275\u2013292."}, {"Citation": "Wu, Q., Yang, Z., Nie, Y., Shi, Y., & Fan, D. (2014). Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches. Cancer letters, 347, 159\u2013166.", "ArticleIdList": ["24657660"]}, {"Citation": "Rezaei, T., Amini, M., Hashemi, Z. S., Mansoori, B., Rezaei, S., Karami, H., Mosafer, J., Mokhtarzadeh, A., & Baradaran, B. (2019). microRNA-181 serves as a dual-role regulator in the development of human cancers. Free Radical Biology and Medicine, 152, 432\u2013454.", "ArticleIdList": ["31899343"]}, {"Citation": "Deng, Y., Wang, C. C., Choy, K. W., Du, Q., Chen, J., Wang, Q., Li, L., Chung, T. K. H., & Tang, T. (2014). Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies. Gene, 538, 217\u2013227.", "ArticleIdList": ["24406620"]}, {"Citation": "Jebelli, A., Baradaran, B., Mosafer, J., Baghbanzadeh, A., Mokhtarzadeh, A., & Tayebi, L. (2021). Recent developments in targeting genes and pathways by RNAi-based approaches in colorectal cancer. Medicinal Research Reviews, 41, 395\u2013434.", "ArticleIdList": ["32990372"]}, {"Citation": "Ivkovic, T. C., Voss, G., Cornella, H., & Ceder, Y. (2017). microRNAs as cancer therapeutics: A step closer to clinical application. Cancer Letters, 407, 113\u2013122."}, {"Citation": "Ji, W., Sun, B., & Su, C. (2017). Targeting microRNAs in cancer gene therapy. Genes, 8, 21.", "ArticleIdList": ["28075356", "5295016"]}, {"Citation": "Svoronos, A. A., Engelman, D. M., & Slack, F. J. (2016). OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Research, 76, 3666\u20133670.", "ArticleIdList": ["27325641", "4930690"]}, {"Citation": "Ni, W. J., & Leng, X. M. (2015). Dynamic miRNA-mRNA paradigms: New faces of miRNAs. Biochemistry and Biophysics Reports, 4, 337\u2013341.", "ArticleIdList": ["29124222", "5669400"]}, {"Citation": "Reddy, K. B. (2015). MicroRNA (miRNA) in cancer. Cancer Cell International, 15, 1\u20136."}, {"Citation": "Bai, S., Nasser, M. W., Wang, B., Hsu, S.-H., Datta, J., Kutay, H., Yadav, A., Nuovo, G., Kumar, P., & Ghoshal, K. (2009). MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. Journal of Biological Chemistry, 284, 32015\u201332027.", "ArticleIdList": ["19726678", "2797273"]}, {"Citation": "Zhou, X., Jin, W., Jia, H., Yan, J., & Zhang, G. (2015). MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7. Journal of Experimental & Clinical Cancer Research, 34, 1\u201314."}, {"Citation": "Chai, B., Guo, Y., Cui, X., Liu, J., Suo, Y., Dou, Z., & Li, N. (2019). MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1. American Journal of Translational Research, 11, 4516.", "ArticleIdList": ["31396355", "6684915"]}, {"Citation": "Chen, Y., Gao, D. Y., & Huang, L. (2015). In vivo delivery of miRNAs for cancer therapy: Challenges and strategies. Advanced Drug Delivery Reviews, 81, 128\u2013141.", "ArticleIdList": ["24859533"]}, {"Citation": "Abd-Aziz, N., Kamaruzman, N. I., & Poh, C. L. (2020). Development of MicroRNAs as potential therapeutics against cancer. Journal of Oncology, 2020, 8029721.", "ArticleIdList": ["32733559", "7378626"]}, {"Citation": "Bader, A., Brown, D., Stoudemire, J., & Lammers, P. (2011). Developing therapeutic microRNAs for cancer. Gene Therapy, 18, 1121\u20131126.", "ArticleIdList": ["21633392", "3910432"]}, {"Citation": "Jahanafrooz, Z., Motamed, N., Rinner, B., Mokhtarzadeh, A., & Baradaran, B. (2018). Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator. Life Sciences, 213, 236\u2013247.", "ArticleIdList": ["30308184"]}, {"Citation": "Ledesma-Mart\u00ednez, E., Mendoza-N\u00fa\u00f1ez, V. M., & Santiago-Osorio, E. (2016). Mesenchymal stem cells derived from dental pulp: A review. Stem Cells International, 2016, 4709572\u20134709572.", "ArticleIdList": ["26779263"]}, {"Citation": "Graves, P., & Zeng, Y. (2012). Biogenesis of mammalian microRNAs: A global view. Genomics, Proteomics & Bioinformatics, 10, 239\u2013245."}, {"Citation": "Feng, T., Xu, D., Tu, C., Li, W., Ning, Y., Ding, J., Wang, S., Yuan, L., Xu, N., & Qian, K. (2015). MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. Tumor Biology, 36, 5987\u20135997.", "ArticleIdList": ["25731732"]}, {"Citation": "Kloosterman, W. P., & Plasterk, R. H. (2006). The diverse functions of microRNAs in animal development and disease. Developmental Cell, 11, 441\u2013450.", "ArticleIdList": ["17011485"]}, {"Citation": "Pfaff, J., & Meister, G. (2013). Argonaute and GW182 proteins: An effective alliance in gene silencing. Portland Press Ltd."}, {"Citation": "Hussain, M. U. (2012). Micro-RNAs (miRNAs): Genomic organisation, biogenesis and mode of action. Cell and Tissue Research, 349, 405\u2013413."}, {"Citation": "Braun, J. E., Huntzinger, E., & Izaurralde, E. (2013). The role of GW182 proteins in miRNA-mediated gene silencing. Ten years of progress in GW/P body research (pp. 147\u2013163). Springer."}, {"Citation": "Zhang, X., Wu, M., Chong, Q.-Y., Zhang, W., Qian, P., Yan, H., Qian, W., Zhang, M., Lobie, P. E., & Zhu, T. (2018). Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1. Carcinogenesis, 39, 1506\u20131516.", "ArticleIdList": ["30084985"]}, {"Citation": "Zhang, L. F., Zhang, J. G., Zhou, H., Dai, T. T., Guo, F. B., Xu, S. Y., & Chen, Y. (2020). MicroRNA-425-5p promotes breast cancer cell growth by inducing PI3K/AKT signaling. The Kaohsiung Journal of Medical Sciences, 36, 250\u2013256.", "ArticleIdList": ["31688991"]}, {"Citation": "Jiang, L., Ge, W., & Geng, J. (2019). miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer. Pathology-Research and Practice, 215, 152705.", "ArticleIdList": ["31685299"]}, {"Citation": "Zhang, Z., Li, Y., Fan, L., Zhao, Q., Tan, B., Li, Z., & Zang, A. (2015). microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo. Experimental and Therapeutic Medicine, 9, 1617\u20131622.", "ArticleIdList": ["26136868", "4471687"]}, {"Citation": "Fu, Y., Li, Y., Wang, X., Li, F., & Lu, Y. (2020). Overexpression of miR-425\u20135p is associated with poor prognosis and tumor progression in non-small cell lung cancer. Cancer Biomarkers, 27, 1\u201310."}, {"Citation": "Wang, Z., Tang, Y., Xie, L., Huang, A., Xue, C., Gu, Z., Wang, K., & Zong, S. (2019). The prognostic and clinical value of CD44 in colorectal cancer: A meta-analysis. Frontiers in Oncology, 9, 309.", "ArticleIdList": ["31114754", "6503057"]}, {"Citation": "Yang, X., He, Q., Guo, Z., Xiong, F., Li, Y., Pan, Y., Gao, C., Li, L., & He, C. (2018). MicroRNA-425 facilitates pathogenic Th17 cell differentiation by targeting forkhead box O1 (Foxo1) and is associated with inflammatory bowel disease. Biochemical and Biophysical Research Communications, 496, 352\u2013358.", "ArticleIdList": ["29331376"]}, {"Citation": "Ren, R.-J., Zhang, Y.-F., Dammer, E. B., Zhou, Y., Wang, L.-L., Liu, X.-H., Feng, B.-L., Jiang, G.-X., Chen, S.-D., Wang, G., & Cheng, Q. (2016). Peripheral blood MicroRNA expression profiles in Alzheimer\u2019s disease: Screening, validation, association with clinical phenotype and implications for molecular mechanism. Molecular Neurobiology, 53, 5772\u20135781.", "ArticleIdList": ["26497032"]}, {"Citation": "Liu, S., Wang, Q., Liu, Y., & Xia, Z.-Y. (2019). miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3\u03b2 and inactivating the Wnt/\u03b2-catenin signaling pathway. Journal of Biosciences, 44, 102.", "ArticleIdList": ["31502580"]}, {"Citation": "Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87\u2013108.", "ArticleIdList": ["25651787"]}, {"Citation": "Mansoori, B., Najafi, S., Mohammadi, A., AsadollahSeraj, H., Savadi, P., Mansoori, B., Nazari, A., Mokhtarzadeh, A., Roshani, E., Duijf, P. H., Cho, W. C., & Baradaran, B. (2021). The synergy between miR-486\u20135p and tamoxifen causes profound cell death of tamoxifen-resistant breast cancer cells. Biomedicine & Pharmacotherapy = Biomedecine & pharmacotherapie, 141, 111925."}, {"Citation": "Backer, J. M. (2010). The regulation of class IA PI 3-kinases by inter-subunit interactions. Phosphoinositide 3-kinase in Health and Disease (pp. 87\u2013114). Springer."}, {"Citation": "Schnitt, S. J. (2010). Classification and prognosis of invasive breast cancer: From morphology to molecular taxonomy. Modern Pathology, 23, S60\u2013S64.", "ArticleIdList": ["20436504"]}, {"Citation": "Tseng, L., Hsu, N., Chen, S., Lu, Y., Lin, C., Chang, D., Li, H., Lin, Y., Chang, H., & Chao, T. (2013). Distant metastasis in triple-negative breast cancer. Neoplasma, 60, 290\u2013294.", "ArticleIdList": ["23373998"]}, {"Citation": "Yao, Y., Chu, Y., Xu, B., Hu, Q., & Song, Q. (2019). Risk factors for distant metastasis of patients with primary triple-negative breast cancer. Bioscience Reports, 39, 6."}, {"Citation": "Di Leva, G., Piovan, C., Gasparini, P., Ngankeu, A., Taccioli, C., Briskin, D., Cheung, D. G., Bolon, B., Anderlucci, L., & Alder, H. (2013). Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genetics, 9, e1003311.", "ArticleIdList": ["23505378", "3591271"]}, {"Citation": "Yan, Y., Gong, F., Wang, B., & Zheng, W. (2017). MiR-425-5p promotes tumor progression via modulation of CYLD in gastric cancer. European Review for Medical and Pharmacological Sciences, 21, 2130\u20132136.", "ArticleIdList": ["28537672"]}, {"Citation": "Sun, S.-C. (2010). CYLD: A tumor suppressor deubiquitinase regulating NF-\u03ba B activation and diverse biological processes. Cell Death & Differentiation, 17, 25\u201334."}, {"Citation": "Verhoeft, K. R., Ngan, H. L., & Lui, V. W. Y. (2016). The cylindromatosis (CYLD) gene and head and neck tumorigenesis. Cancers of the Head & Neck, 1, 10."}, {"Citation": "Xia, Y., Shen, S., & Verma, I. M. (2014). NF-\u03baB, an active player in human cancers. Cancer Immunology Research, 2, 823\u2013830.", "ArticleIdList": ["25187272", "4155602"]}, {"Citation": "Ma, J., Liu, J., Wang, Z., Gu, X., Fan, Y., Zhang, W., Xu, L., Zhang, J., & Cai, D. (2014). NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1\u03b2 induction. Molecular Cancer, 13, 40.", "ArticleIdList": ["24571667", "3941686"]}, {"Citation": "Zhang, Z., Wen, M., Guo, J., Shi, J., Wang, Z., Tan, B., Zhang, G., Zheng, X., & Zhang, A. (2017). Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer. Pathology-Research and Practice, 213, 929\u2013937.", "ArticleIdList": ["28647207"]}, {"Citation": "Tunissiolli, N. M., Castanhole-Nunes, M. M. U., Biselli-Chicote, P. M., Pavarino, \u00c9. C., & da Silva, R. F. (2017). Hepatocellular carcinoma: A comprehensive review of biomarkers, clinical aspects, and therapy. Asian Pacific Journal of Cancer Prevention: APJCP, 18, 863.", "ArticleIdList": ["28545181", "5494234"]}, {"Citation": "Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019). A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nature Reviews Gastroenterology & Hepatology, 16, 1\u201316."}, {"Citation": "Fang, F., Song, T., Zhang, T., Cui, Y., Zhang, G., & Xiong, Q. (2017). MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways. Oncotarget, 8, 31745.", "ArticleIdList": ["28423650", "5458244"]}, {"Citation": "Yao, X., Liu, C., Liu, C., Xi, W., Sun, S., & Gao, Z. (2019). lncRNA SNHG7 sponges miR-425 to promote proliferation, migration, and invasion of hepatic carcinoma cells via Wnt/\u03b2-catenin/EMT signalling pathway. Cell Biochemistry and Function, 37, 525\u2013533.", "ArticleIdList": ["31478234", "6851833"]}, {"Citation": "Mohammadi, A., Mansoori, B., Duijf, P. H., Safarzadeh, E., Tebbi, L., Najafi, S., Shokouhi, B., Sorensen, G. L., Holmskov, U., & Baradaran, B. (2021). Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration. Journal of cellular physiology, 236, 273\u2013283.", "ArticleIdList": ["32583462"]}, {"Citation": "Fu, Y., Li, Y., Wang, X., Li, F., & Lu, Y. (2019). Overexpression of miR-425\u20135p is associated with poor prognosis and tumor progression in non-small cell lung cancer. Cancer Biomarkers, 27, 1\u201310."}, {"Citation": "Yu, X., Zheng, H., Sun, R., Qian, X., Jiang, P., Yang, B., Liu, J., & Li, X. (2020). MicroRNA-425-5p inhibits lung cancer cell growth in vitro and in vivo by downregulating TFIIB-related factor 2. Technology in Cancer Research & Treatment, 19, 1533033819901115."}, {"Citation": "Liu, R., Wang, F., Guo, Y., Yang, J., Chen, S., Gao, X., & Wang, X. (2018). MicroRNA-425 promotes the development of lung adenocarcinoma via targeting A disintegrin and metalloproteinases 9 (ADAM9). OncoTargets and Therapy, 11, 4065.", "ArticleIdList": ["30038506", "6052924"]}, {"Citation": "Moore, D. H. (2006). Cervical cancer. Obstetrics & Gynecology, 107, 1152\u20131161."}, {"Citation": "Sun, L., Jiang, R., Li, J., Wang, B., Ma, C., Lv, Y., & Mu, N. (2017). MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Annals of Clinical Biochemistry, 54, 127\u2013133.", "ArticleIdList": ["27166306"]}, {"Citation": "Zhang, Y., Yang, Y., Liu, R., Meng, Y., Tian, G., & Cao, Q. (2019). Downregulation of microRNA-425-5p suppresses cervical cancer tumorigenesis by targeting AIFM1. Experimental and Therapeutic Medicine, 17, 4032\u20134038.", "ArticleIdList": ["30988784", "6447898"]}, {"Citation": "Van der Jeught, K., Xu, H.-C., Li, Y.-J., Lu, X.-B., & Ji, G. (2018). Drug resistance and new therapies in colorectal cancer. World Journal of Gastroenterology, 24, 3834.", "ArticleIdList": ["30228778", "6141340"]}, {"Citation": "Araghi, M., Soerjomataram, I., Jenkins, M., Brierley, J., Morris, E., Bray, F., & Arnold, M. (2019). Global trends in colorectal cancer mortality: Projections to the year 2035. International Journal of Cancer, 144, 2992\u20133000.", "ArticleIdList": ["30536395"]}, {"Citation": "Jahanafrooz, Z., Mosafer, J., Akbari, M., Hashemzaei, M., Mokhtarzadeh, A., & Baradaran, B. (2020). Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. Journal of Cellular Physiology, 235, 4153\u20134166.", "ArticleIdList": ["31647128"]}, {"Citation": "Zhang, Y., & Wang, J. (2017). MicroRNAs are important regulators of drug resistance in colorectal cancer. Biological Chemistry, 398, 929\u2013938.", "ArticleIdList": ["28095367", "5911396"]}, {"Citation": "Sameen, S., Barbuti, R., Milazzo, P., Cerone, A., Del Re, M., & Danesi, R. (2016). Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer. Journal of Theoretical Biology, 389, 263\u2013273.", "ArticleIdList": ["26551156"]}, {"Citation": "Shirmohamadi, M., Eghbali, E., Najjary, S., Mokhtarzadeh, A., Kojabad, A. B., Hajiasgharzadeh, K., Lotfinezhad, P., & Baradaran, B. (2020). Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells. Journal of Cellular Physiology, 235, 776\u2013789.", "ArticleIdList": ["31264216"]}, {"Citation": "Hejazi, M., Baghbani, E., Amini, M., Rezaei, T., Aghanejad, A., Mosafer, J., Mokhtarzadeh, A., & Baradaran, B. (2020). MicroRNA-193a and taxol combination: A new strategy for treatment of colorectal cancer. Journal of Cellular Biochemistry, 121, 1388\u20131399.", "ArticleIdList": ["31512793"]}, {"Citation": "Porru, M., Pompili, L., Caruso, C., Biroccio, A., & Leonetti, C. (2018). Targeting KRAS in metastatic colorectal cancer: Current strategies and emerging opportunities. Journal of Experimental & Clinical Cancer Research, 37, 1\u201310."}, {"Citation": "Bahrami, A., Hassanian, S. M., ShahidSales, S., Farjami, Z., Hasanzadeh, M., Anvari, K., Aledavood, A., Maftouh, M., Ferns, G. A., & Khazaei, M. (2018). Targeting RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer. Journal of Cellular Physiology, 233, 2058\u20132066.", "ArticleIdList": ["28262927"]}, {"Citation": "Angius, A., Pira, G., Scanu, A. M., Uva, P., Sotgiu, G., Saderi, L., Manca, A., Serra, C., Uleri, E., & Piu, C. (2019). MicroRNA-425-5p expression affects BRAF/RAS/MAPK pathways in colorectal cancers. International Journal of Medical Sciences, 16, 1480.", "ArticleIdList": ["31673240", "6818206"]}, {"Citation": "Zhang, Y., Hu, X., Miao, X., Zhu, K., Cui, S., Meng, Q., Sun, J., & Wang, T. (2016). Micro RNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of programmed cell death 10. Journal of Cellular and Molecular Medicine, 20, 360\u2013369.", "ArticleIdList": ["26647742"]}, {"Citation": "Jan\u010d\u00edk, S., Dr\u00e1bek, J., Radzioch, D., & Hajd\u00fach, M. (2010). Clinical relevance of KRAS in human cancers. BioMed Research International. https://doi.org/10.1155/2010/150960", "ArticleIdList": ["10.1155/2010/150960"]}, {"Citation": "Markman, B., Javier Ramos, F., Capdevila, J., & Tabernero, J. (2010). EGFR and KRAS in colorectal cancer. Advances in Clinical Chemistry, 51, 72."}, {"Citation": "Crist\u00f3bal, I., Madoz-G\u00farpide, J., Rojo, F., & Garc\u00eda-Foncillas, J. (2016). Potential therapeutic value of miR-425-5p in metastatic colorectal cancer. Journal of Cellular and Molecular Medicine, 20, 2213.", "ArticleIdList": ["27396018", "5082410"]}, {"Citation": "Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018). The epidemiology of prostate cancer. Cold Spring Harbor Perspectives in Medicine, 8, a030361.", "ArticleIdList": ["29311132", "6280714"]}, {"Citation": "Zhou, H., Liu, H., Jiang, M., Zhang, S., Chen, J., & Fan, X. J. C. T. (2019). Targeting MicroRNA-21 suppresses gastric cancer cell proliferation and migration via PTEN/Akt signaling axis. Cell Transplantation, 28, 306\u2013317.", "ArticleIdList": ["30700111", "6425105"]}, {"Citation": "Landgren, H., & Carlsson, P. (2004). FoxJ3, a novel mammalian forkhead gene expressed in neuroectoderm, neural crest, and myotome. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 231, 396\u2013401.", "ArticleIdList": ["15366017"]}, {"Citation": "Cai, Q., Zhao, A., Ren, L., Chen, J., Liao, K., Wang, Z., & Zhang, W. (2018). MiR-425 involves in the development and progression of renal cell carcinoma by inhibiting E2F6. European Review for Medical and Pharmacological Sciences, 22, 6300\u20136307.", "ArticleIdList": ["30338798"]}, {"Citation": "Quan, J., Li, Y., Pan, X., Lai, Y., He, T., Lin, C., Zhou, L., Zhao, L., Sun, S., & Ding, Y. (2018). Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. Oncology Letters, 16, 2175\u20132184.", "ArticleIdList": ["30008916", "6036448"]}, {"Citation": "Wojcicka, A., Piekielko-Witkowska, A., Kedzierska, H., Rybicka, B., Poplawski, P., Boguslawska, J., Master, A., & Nauman, A. (2014). Epigenetic regulation of thyroid hormone receptor beta in renal cancer. PLoS ONE, 9, e97624.", "ArticleIdList": ["24849932", "4029725"]}, {"Citation": "Cao, S., Zheng, J., Liu, X., Liu, Y., Ruan, X., Ma, J., Liu, L., Wang, D., Yang, C., & Cai, H. (2019). FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG. Journal of Experimental & Clinical Cancer Research, 38, 37."}, {"Citation": "Lauber, K., Ernst, A., Orth, M., Herrmann, M., & Belka, C. (2012). Dying cell clearance and its impact on the outcome of tumor radiotherapy. Frontiers in Oncology, 2, 116.", "ArticleIdList": ["22973558", "3438527"]}, {"Citation": "Moskwa, P., Zinn, P. O., Choi, Y. E., Shukla, S. A., Fendler, W., Chen, C. C., Lu, J., Golub, T. R., Hjelmeland, A., & Chowdhury, D. (2014). A functional screen identifies miRs that induce radioresistance in glioblastomas. Molecular Cancer Research, 12, 1767\u20131778.", "ArticleIdList": ["25256711"]}, {"Citation": "Liu, P., Hu, Y., Ma, L., Du, M., Xia, L., & Hu, Z. (2015). miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1. Biomedicine & Pharmacotherapy, 75, 51\u201357."}, {"Citation": "Yang, C., Shao, T., Zhang, H., Zhang, N., Shi, X., Liu, X., Yao, Y., Xu, L., Zhu, S., & Cao, J. (2018). MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. Journal of Translational Medicine, 16, 267.", "ArticleIdList": ["30285885", "6167790"]}, {"Citation": "He, B., Li, T., Guan, L., Liu, F.-E., Chen, X.-M., Zhao, J., Lin, S., Liu, Z.-Z., & Zhang, H.-Q. (2016). CTNNA3 is a tumor suppressor in hepatocellular carcinomas and is inhibited by miR-425. Oncotarget, 7, 8078.", "ArticleIdList": ["26882563", "4884977"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "2", "Day": "28"}, {"Year": "2023", "Month": "4", "Day": "17"}, {"Year": "2024", "Month": "7", "Day": "1", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "19", "Hour": "0", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "18", "Hour": "23", "Minute": "38"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37332071", "10.1007/s12033-023-00756-5", "10.1007/s12033-023-00756-5"]}}], "PubmedBookArticle": []}